| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/14/2005 | CA2551024A1 Maize metallothionein 2 promoter and methods of use |
| 07/14/2005 | CA2551023A1 Maize metallothionein promoter |
| 07/14/2005 | CA2551011A1 Plant activation of insect toxin |
| 07/14/2005 | CA2550927A1 A gram negative bacterium with reduced lps level in the outer membrane and use thereof for treating gram negative bacterial infection |
| 07/14/2005 | CA2550833A1 Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent |
| 07/14/2005 | CA2550727A1 Treatment of coronary or peripheral ischemia |
| 07/14/2005 | CA2550455A1 Haemophilus influenzae type iv pili |
| 07/14/2005 | CA2550356A1 Heh4 molecules and uses thereof |
| 07/14/2005 | CA2548940A1 Process for the production of tumor necrosis factor-binding proteins |
| 07/14/2005 | CA2548378A1 A process for the preparation and purification of recombinant proteins |
| 07/14/2005 | CA2548181A1 Anti-retroviral agents, compositions, methods and uses |
| 07/14/2005 | CA2544334A1 Cc-chemokine-binding tick proteins |
| 07/14/2005 | CA2544333A1 Method for purifying fsh |
| 07/13/2005 | EP1553515A1 Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation |
| 07/13/2005 | EP1553190A2 Mutations in and genomic structure of HERG - a long QT syndrome gene |
| 07/13/2005 | EP1553183A1 Nucleic acid encoding mirafiori lettuce virus protein and utilization thereof |
| 07/13/2005 | EP1553182A2 Regulated genes and uses thereof |
| 07/13/2005 | EP1553180A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide |
| 07/13/2005 | EP1553179A1 Mouse-origin proteins forming domain or use thereof |
| 07/13/2005 | EP1553178A1 Tumor-lysing virus growing selectively in tumor cells |
| 07/13/2005 | EP1553177A1 Method of designing physiologically active peptide and use thereof |
| 07/13/2005 | EP1553174A2 Enzymes and detergent compositons |
| 07/13/2005 | EP1553173A2 Enzymes and detergent compositions |
| 07/13/2005 | EP1553169A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 07/13/2005 | EP1553168A2 Methods for selectively stimulating proliferation of T cells |
| 07/13/2005 | EP1552852A1 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 07/13/2005 | EP1552847A1 Inhibitors for continuous activation of calcineurin |
| 07/13/2005 | EP1552845A1 Preventives/remedies for cancer |
| 07/13/2005 | EP1552740A1 Chimeric murine model comprising human hepatocytes - use for screening compounds |
| 07/13/2005 | EP1552462A1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 07/13/2005 | EP1552309A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN |
| 07/13/2005 | EP1552298A2 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 07/13/2005 | EP1552020A2 Lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosis |
| 07/13/2005 | EP1552016A2 Methods for vaccine identification and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the herpesvirus family |
| 07/13/2005 | EP1551987A1 Protein modification |
| 07/13/2005 | EP1551983A2 Identification of e2f target genes and uses thereof |
| 07/13/2005 | EP1551982A1 Transcriptional control element, chimeric constructs and uses therefor |
| 07/13/2005 | EP1551981A1 Expressional enhancers from viruses |
| 07/13/2005 | EP1551979A2 Compositions and methods for treatment and detection of multiple cancers |
| 07/13/2005 | EP1551978A2 Nell-1 enhanced bone mineralization |
| 07/13/2005 | EP1551977A1 Selective, local activation of members of the tnf ligand family of systemically inactive non-antibody tnf ligand fusion proteins |
| 07/13/2005 | EP1551975A2 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
| 07/13/2005 | EP1551973A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551970A2 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 07/13/2005 | EP1551968A2 Pathogen-responsive genes, promoters, regulatory elements, and methods of use for same |
| 07/13/2005 | EP1551964A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 07/13/2005 | EP1551963A1 Improved immunotherapy |
| 07/13/2005 | EP1551962A2 Mitotic kinesin binding site |
| 07/13/2005 | EP1551960A2 Hepatitis c viral-like particle purification |
| 07/13/2005 | EP1551959A2 Modulators of chloride intracellular channel 1 protein signaling |
| 07/13/2005 | EP1551957A2 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 07/13/2005 | EP1551951A1 Genetically modified microorganisms, plasmid and fermentation process with the presence of flocculation regulated by medium changes |
| 07/13/2005 | EP1551874A2 Alpha macroglobulin protein family members |
| 07/13/2005 | EP1551873A1 Agonists and antagonists of the human odorant receptor or17-4 and uses thereof |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551871A2 Rad51-brc repeat crystals |
| 07/13/2005 | EP1551870A2 Glycosylated human granulocyte colony-stimulating factor (g-csf) isoform |
| 07/13/2005 | EP1551869A2 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 07/13/2005 | EP1551868A2 Factor involved in metastasis and uses thereof |
| 07/13/2005 | EP1551866A1 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a thioredoxin-like 32 kda protein |
| 07/13/2005 | EP1551862A1 Protein lattice |
| 07/13/2005 | EP1551861A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/13/2005 | EP1551856A2 Novel therapeutic target for treating vascular diseases, dyslipidemias and related disorders |
| 07/13/2005 | EP1551773A2 Ammonia-oxidizing bacteria and methods of using and detecting the same |
| 07/13/2005 | EP1551762A2 Peptide derivatives, and their use for the synthesis of silicon-based composite materials |
| 07/13/2005 | EP1551449A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 07/13/2005 | EP1551448A2 Targeted cd1d molecules |
| 07/13/2005 | EP1551447A2 Anti-addl antibodies and uses thereof |
| 07/13/2005 | EP1551446A1 Neuroendocrine marker for cancer and method for producing same |
| 07/13/2005 | EP1551444A2 Method for treatment of demyelinating central nervous system disease using gm-csf |
| 07/13/2005 | EP1551441A1 Peptides and recombinant proteins mimicking interferons |
| 07/13/2005 | EP1551440A2 Uses of human zven proteins and polynucleotides |
| 07/13/2005 | EP1551438A2 Analogs of parathyroid hormone and pth-related protein as bone anabolic agents |
| 07/13/2005 | EP1551437A2 Methods and compositions for detecting cancers |
| 07/13/2005 | EP1551435A2 Method for enzymatic production of glp-1 (7-36) amide peptides |
| 07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/13/2005 | EP1551291A2 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes |
| 07/13/2005 | EP1551222A2 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 07/13/2005 | EP1451341A4 Eit-6, a polypeptide encoded by an estrogen regulated gene |
| 07/13/2005 | EP0804548B1 Patched genes and their use |
| 07/13/2005 | EP0698099B1 Method for the culture in vitro of different stages of tissue parasites |
| 07/13/2005 | EP0681431B1 Production of human recombinant collagen in the milk of transgenic animals |
| 07/13/2005 | EP0394296B2 Assay of a body fluid for measuring bone resorption |
| 07/13/2005 | CN1639574A Serological assay for neospora caninum |
| 07/13/2005 | CN1639572A Assay for anti-INGAP antibodies |
| 07/13/2005 | CN1639570A Proteins with repetitive bacterial-ig-like (BIG) domains present in leptospira species |
| 07/13/2005 | CN1639569A Methods and compositions for inducing an immune response |
| 07/13/2005 | CN1639343A Method for detection of leptin receptor ligands |
| 07/13/2005 | CN1639342A Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 07/13/2005 | CN1639338A Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 07/13/2005 | CN1639333A Process for producing physiologically active protein using genetically modified silkworm |
| 07/13/2005 | CN1639331A Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 07/13/2005 | CN1639324A Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 07/13/2005 | CN1639323A Vesicles derived from T cells, production and uses |
| 07/13/2005 | CN1639320A Cold shock inducible expression and production of heterologous polypeptides |
| 07/13/2005 | CN1639318A Antimicrobial composition |
| 07/13/2005 | CN1639194A Antibodies against cancer |
| 07/13/2005 | CN1639193A Antibodies against fibroblast growth factor 23 |
| 07/13/2005 | CN1639191A 鼠李糖结合蛋白 Rhamnose-binding protein |